Pharmacyclics (PCYC)

Add to Watchlists
Create an Alert
89.75 -0.29  -0.32% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
PCYC Price Chart
View All Events

PCYC Events

Date Type Description
Feb 20 Misc Pharmacyclics, Inc. Q4 2013 Earning Conference Call
Feb 20 Earnings Pharmacyclics, Inc. Q4 2013 Earning Result. Estimate: 0.77.
Nov 05 Misc Pharmacyclics Announces Date of Conference Call to Discuss Financial Results for Third Quarter Ended September 30, 2013
Nov 05 Earnings Pharmacyclics Announces Date of Conference Call to Discuss Financial Results Conference Call. Estimate: 0.30.
Jul 31 Misc Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
Jul 31 Earnings Pharmacyclics, Inc. Second Quarter Earnings Results. Estimate: -0.05.
May 01 Misc Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
May 01 Earnings Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013. Estimate: -0.08.
View All Performance Charts

PCYC Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pharmacyclics is up 20.16% over the last year vs S&P 500 Total Return up 22.72%, Johnson & Johnson up 21.44%, and Celgene up 16.62%.

Get Quote for

PDF Report for PCYC

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download PCYC Pro Report PDF
Advertisement

Portfolio Strategies Featuring PCYC

Did Pharmacyclics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PCYC Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. The company has three proprietary drug candidates under clinical development and several preclinical lead molecules which includes Bruton's tyrosine kinase inhibitor, Btk inhibitor lead optimization program and histone deacetylase inhibitor. The company was founded on April 19, 1991 and is headquartered in Sunnyvale, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PCYC 89.75 -0.29 -0.32% 6.657B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.